Price T Rowe Associates Inc Allakos Inc. Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Allakos Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 620,457 shares of ALLK stock, worth $874,844. This represents 0.0% of its overall portfolio holdings.

Number of Shares

620,457

Previous 638,102 2.77%

Holding current value

$874,844

Previous $805,000 22.86%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.0 - $1.45 $17,645 - $25,585	-17,645 Reduced 2.77%	620,457 $621,000
Q1 2024 May 15, 2024	SELL	$1.02 - $3.23 $7.43 Million - $23.5 Million	-7,282,606 Reduced 91.94%	638,102 $805,000
Q4 2023 Feb 14, 2024	BUY	$1.72 - $3.18 $2.72 Million - $5.02 Million	1,578,631 Added 24.89%	7,920,708 $21.6 Million
Q3 2023 Nov 14, 2023	BUY	$2.13 - $5.55 $5.3 Million - $13.8 Million	2,490,154 Added 64.65%	6,342,077 $14.4 Million
Q2 2023 Aug 14, 2023	BUY	$3.6 - $5.25 $9.55 Million - $13.9 Million	2,651,450 Added 220.87%	3,851,923 $16.8 Million
Q1 2023 May 15, 2023	SELL	$4.3 - $8.27 $214,828 - $413,169	-49,960 Reduced 4.0%	1,200,473 $5.34 Million
Q4 2022 Feb 14, 2023	BUY	$5.66 - $8.42 $2.55 Million - $3.8 Million	451,058 Added 56.43%	1,250,433 $10.5 Million
Q3 2022 Nov 14, 2022	BUY	$3.02 - $6.12 $547,175 - $1.11 Million	181,184 Added 29.31%	799,375 $4.89 Million
Q2 2022 Aug 15, 2022	SELL	$2.6 - $6.14 $144,417 - $341,046	-55,545 Reduced 8.24%	618,191 $1.94 Million
Q1 2022 May 16, 2022	BUY	$5.08 - $9.81 $2.19 Million - $4.23 Million	431,599 Added 178.25%	673,736 $3.84 Million
Q4 2021 Feb 14, 2022	BUY	$8.55 - $111.89 $1.94 Million - $25.3 Million	226,340 Added 1432.8%	242,137 $2.37 Million
Q3 2021 Nov 15, 2021	BUY	$76.53 - $110.43 $66,734 - $96,294	872 Added 5.84%	15,797 $1.67 Million
Q2 2021 Aug 16, 2021	BUY	$85.37 - $114.1 $136,677 - $182,674	1,601 Added 12.02%	14,925 $1.27 Million
Q1 2021 May 17, 2021	BUY	$109.73 - $153.66 $32,809 - $45,944	299 Added 2.3%	13,324 $1.53 Million
Q4 2020 Feb 16, 2021	BUY	$79.58 - $152.45 $1.04 Million - $1.99 Million	13,025 New	13,025 $1.82 Million

Others Institutions Holding ALLK

# of Institutions

Shares Held

70.7M

Call Options Held

43.8K

Put Options Held

1.4K

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $119M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Allakos Inc. Transaction History